IRCT20210926052602N1
Recruiting
Phase 3
Comparison of the effect of Metformin and Empagliflozin in treatment of prediabetic patients.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Prediabetes.
- Sponsor
- Kashan University of Medical Sciences
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prediabetic patient
- •Age between 30\-80 years old
Exclusion Criteria
- •Treatment with hormones or drugs that interference glucose metabolism
- •Neurogenic bladder disorder
- •Pregnant or breast feeding mothers
- •Allergy to Empagliflozin or Metformin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50
Not Yet Recruiting
Phase 3
Investigation of the effect of metformin gel on severe chronic periodontitisIRCT20200623047900N1Zahedan University of Medical Sciences50
Recruiting
Phase 3
Effect of metformin and L-carnitine in treatment of fatty livernon alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20150706023083N3Tabriz University of Medical Sciences68
Completed
N/A
Comparison of therapeutic effects of metformin and simvastatin in PCOSPCOS.Polycystic ovarian syndromeIRCT201012285487N2Alzahra Hospital Research Center60
Completed
N/A
Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93